Skip to content
The Policy VaultThe Policy Vault

Savaysa (edoxaban tablets) — Cigna

Atrial Fibrillation (or Atrial Flutter)

Initial criteria

  • Patient age ≥ 18 years
  • Patient has an estimated creatinine clearance ≤ 95 mL/min

Approval duration

1 year